Dear Reader,

I'm excited to share some remarkable news about a recent scientific breakthrough my colleagues and I achieved in hair loss prevention and regeneration.

This discovery can not only give people back a full, thick head of hair; it can do so virtually painlessly and quite affordably. In fact, no other hair therapy on the market today addresses the real reason hair is falling out in the first place. We now know that in most cases the hair follicles don't die, as previously thought. Instead, they inflame and, due to nutritional deprivation, become trapped in a fibrous capsule in a dormant but alive state. It is a process we define as Follicle Nutrient Deficiency Syndrome (FNDS).

Shortly after discovering the real science behind the causal effect of hair loss, we headed back into the lab in search of a solution – a formula – that could release the trapped follicles and provide the ideal mixture of nutrients, minerals and vitamins FNDS prevents the body from being able to deliver.

Twelve years of hard work and solution-driven focus paid off and led to these remarkable results over the next eight years ...

MORE THAN 30,000 PRE-CLINICAL TRIAL TREATMENTS WERE ADMINISTERED TO MORE THAN 5,000 PATIENTS WITH ABOUT 9 OUT OF 10 REGROWING THEIR OWN NATURAL HAIR

On June 30, 2004, twelve years after the research had begun, I assembled a select private consortium of medical clinics located in South America to conduct pre-clinical-trial treatments on patients suffering from FNDS and offer preventive treatment to those wishing to avoid FNDS. My team of clinicians report they have subjectively observed virtually 100% of preventive care patients continue to retain their healthy hair; in addition, an estimated 80-85% of the males and 90-plus% of the females treated for hair regeneration experienced significant regrowth of their own natural hair. And among alopecia areata patients, regrowth results were observed to be nearly 100% effective.

The group of patients treated has been comprised of approximately 50% males and 50% females. Our oldest patient treated is a female who just turned 83 years young.

Simply stated, the results have been extremely impressive. Even better, no one treated has experienced or reported any negative side effects whatsoever.

FOCUSED ON OBTAINING WORLDWIDE REGULATORY APPROVAL

Our 20-year journey, culminating with outstanding practical success for more than 5,000 people, has led us to where we are today – rapidly working to achieve worldwide regulatory approvals for the Biologix Hair Therapy System™.

Currently, Biologix Hair Science Ltd., a wholly owned subsidiary of Biologix Hair Inc., is working together with Beijing Institute of Technology (BIT) to complete a series of examinations and tests prior to commencing formal FDA clinical trials.

BIOLOGIX HAIR IS NOW BUILDING OUT AN INTERNATIONAL NETWORK OF CLINICIANS SEEKING EXCLUSIVE CERTIFICATION AND PURCHASING RIGHTS

The potential for Biologix shareholders to realize substantial benefits – should major FDA and other market approvals be forthcoming – will in part be predicated upon the company’s success in developing a global network of clinicians and doctors to administer treatment.

Biologix Hair Inc. and its subsidiary companies intend to be in a ready position to capitalize on the opportunity to become the dominant leader in the global hair loss industry.

To learn about Clinician Licensing opportunities, Click Here or call toll free +1 855.737.0333 or +1 647.344.5900.

To speak with a Corporate Communications representative, call toll free +1 855.292.8585 or +1 647.494.8001.

Sincerely,

Dr. Guillermo Duran
Inventor of the Biologix Hair Therapy System™
 

Please note: Biologix Hair has decided not to risk creating any potential regulatory conflicts by offering treatment outside the United States and other major high-product-margin markets until FDA approval has been granted, which may or may not be forthcoming. Therefore, the Biologix Hair Therapy System™ is not yet available other than to the 5,000+ patients who participated in the pre-clinical-trials conducted in South America.